The expertise to create cures
Assembly Bio (assemblybio.com) scores 76 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 48th percentile of 9620 Healthcare brands.
Assembly Bio, based in Carmel, United States, and founded in 2014, is a biopharmaceutical company focused on developing novel therapeutics for serious viral and liver diseases. Its research targets chronic hepatitis D, chronic hepatitis B, cholestatic liver diseases, and recurrent genital herpes. The company emphasizes scientific expertise in virology and liver disease to create treatments intended to improve upon current standards of care for patients and the healthcare providers who treat them.
| Brand Name | Assembly Bio |
|---|---|
| Domain | assemblybio.com |
| Industry | Healthcare |
| Founded | 2014 |
| Headquarters | Carmel |
| Main Competitors | Vir Biotechnology (77/100), Gilead Sciences (81/100), Arbutus Biopharma (80/100), Eiger BioPharmaceuticals (53/100), Aligos Therapeutics (77/100), Antios Therapeutics, Mirum Pharmaceuticals (74/100), Intercept Pharmaceuticals (71/100), AiCuris (77/100) |
Moz Domain Authority 39/100 vs category average 41 / leader 97 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #1,211,290 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "The expertise to create cures and life-changing treatments" (Meta description: 8 words. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube; no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Assembly Bio?", Claude could identify the brand as of September 2026. Assembly Biosciences is a clinical-stage biopharmaceutical company focused on developing curative therapies for hepatitis B virus (HBV) and hepatitis D virus (HDV), and has also worked on microbiome-based treatments. Best known for Developing HBV core inhibitor drug candidates aimed at a functional cure for chronic hepatitis B.
When asked "Best brands similar to Assembly Bio?", Claude would recommend Assembly Bio as of September 2026. It's a notable name in the HBV cure research space, so it would come up if discussing companies working toward curing chronic hepatitis B.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Assembly Bio's main competitors in Healthcare: Vir Biotechnology (77/100), Gilead Sciences (81/100), Arbutus Biopharma (80/100), Eiger BioPharmaceuticals (53/100), Aligos Therapeutics (77/100).
Sources: Brand Analyzer scan
Assembly Bio has limited AI-search visibility, scoring 33/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 33, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Assembly Bio official site
Assembly Bio was founded in 2014. Assembly Bio operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Assembly Bio is headquartered in Carmel. Assembly Bio operates in the Healthcare category.
Sources: Wikidata
Assembly Bio researches and develops novel therapeutics aimed at treating serious viral and liver diseases, including chronic hepatitis D, chronic hepatitis B, cholestatic liver diseases, and recurrent genital herpes. The company applies its virology and liver disease expertise to create treatments intended to offer significant advances over existing standards of care.
Sources: Assembly Bio official site
Assembly Bio scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Assembly Bio official site
Assembly Bio develops therapeutic candidates targeting chronic hepatitis D, chronic hepatitis B, cholestatic liver diseases, and recurrent genital herpes. As a biopharmaceutical company, its offerings are in the form of investigational drugs and treatments rather than commercial consumer products.
Sources: Assembly Bio official site
Assembly Bio is a biopharmaceutical company headquartered in Carmel, United States, founded in 2014. It focuses on developing therapies for serious viral and liver diseases, drawing on scientific expertise in virology and liver disease.
Sources: Assembly Bio official site
Assembly Bio can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Assembly Bio official site
Assembly Bio's therapies are intended for patients suffering from serious viral and liver diseases, including chronic hepatitis D, chronic hepatitis B, cholestatic liver diseases, and recurrent genital herpes. Healthcare providers and the broader medical community involved in treating these conditions also engage with the company's research and potential treatments.
Sources: Assembly Bio official site
Assembly Bio is known for its focused work on developing innovative therapeutics for hepatitis D, hepatitis B, cholestatic liver diseases, and recurrent genital herpes, positioning itself as a patient-focused biopharmaceutical company dedicated to addressing serious unmet medical needs in virology and liver disease.
Sources: Assembly Bio official site
Assembly Bio scores 33/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Assembly Bio has a weak AI-visibility profile at 33/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,211,290 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 39/100 and thin schema.org structured data. In a live check, Claude could already identify Assembly Bio from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Assembly Bio: Advanced Sterilization Products (ASP) (76/100), Asepeyo (76/100), Assort Health (76/100), Augmedics (76/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.